Evidence map›Paper›PMID 36312396›Full record

ArticleACS omega2022

Trilobatin, an Active Dihydrochalcone from

Yue-Yang Duan, Xiao-Jie Mi, Wen-Ya Su, Shan Tang, Shuang Jiang, Zi Wang, Li-Chun Zhao, Wei Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yue-Yang DuanCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
Xiao-Jie MiCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
Wen-Ya SuCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
Shan TangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
Shuang JiangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
Zi WangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
Li-Chun ZhaoCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530001, China.
Wei LiCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.ORCID https://orcid.org/0000-0002-2988-4298

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although naturally occurring flavonoids have shown beneficial effects on the side effects caused by cisplatin, there are few reports on the protective effect of dihydrochalcone on the cisplatin-induced toxicity. Trilobatin (TLB), as the major sweetener and active ingredient in

Identifiers

PMID36312396
PMCPMC9607670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.